| abstract |
The present invention relates to a heterocyclic compound of thiazolinone and a process for the preparation thereof, a pharmaceutical composition and a corresponding application. The present invention relates to an application of the heterocyclic thiazolinone compound in the preparation of an NLRP3 inflammasome inhibitor. The heterocyclic thiazolinone compound has a structure of formulas I or II or an isomer, prodrug, or solvate or a pharmaceutically acceptable salt thereof: (I), (II) |